This paper proposes a specialised framework that integrates the Technology Readiness Levels (TRLs) and the Commercial Readiness Index (CRI) to assess learnings from a Horizon 2020 (H2020) project on innovation development via the selection and enhancement of supporting tools and technologies for Nature-based Solutions (NbS) implementation and evaluation. We developed and applied the methodology to scout NbS-related innovations that are at a certain TRL and had the potential for commercial exploitation, and then included tailored activities to help these solutions to reach at least CRI-1 (i.e. have the business model outlined, initial market research done, business case formulated). The tools and technologies were assessed through a lens of innovation, explication, and upscaling. As a result, novel guidelines tailored for NbS innovations were established to introduce a participatory approach in TRL and CRI evaluations to support commercial exploitation for upscaling NbS into mainstream society through market uptake of H2020 frameworks.
No takes yet. Share an insight, caveat, or question.
Penny et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: